Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim
Conditions
Interventions
- GENETIC: RNA analysis
- GENETIC: in situ hybridization
- GENETIC: polymerase chain reaction
- OTHER: enzyme-linked immunosorbent assay
- OTHER: flow cytometry
- OTHER: immunohistochemistry staining method
- OTHER: laboratory biomarker analysis
Sponsor
Eastern Cooperative Oncology Group
Collaborators